TY - JOUR
T1 - Radiolabeling of Gold Nanocages for Potential Applications in Tracking, Diagnosis, and Image-Guided Therapy
AU - Qiu, Jichuan
AU - Liu, Yongjian
AU - Xia, Younan
N1 - Funding Information:
This work was supported in part by startup funds from the Georgia Institute of Technology, a grant from the National Institutes of Health (NIH, R01 CA138527), and an NIH Director's Pioneer Award (DP1 OD000798). Co‐workers and collaborators are acknowledged for their invaluable contributions to this project.
Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2021/8/4
Y1 - 2021/8/4
N2 - Gold nanocages (AuNCs) have emerged as a novel class of multifunctional nanomaterials with an array of applications in nanomedicine, including drug delivery, controlled release, as well as disease diagnosis and treatment. Labeling AuNCs with radionuclides not only offers additional therapeutic capabilities but also makes it easy to analyze their biodistribution, monitor their uptake by the tissue or organ of interest, and optimize their performance in both diagnosis and treatment. Here, an introduction to the chemical synthesis and optical properties of AuNCs is provided in the beginning. The methods developed for their radiolabeling are then showcased, followed by the use of radiolabeled AuNCs in tracking and quantifying their pharmacokinetics, including biodistribution, tumor uptake, and intratumoral distribution. Finally, their potential applications in targeted imaging and image-guided therapy are discussed.
AB - Gold nanocages (AuNCs) have emerged as a novel class of multifunctional nanomaterials with an array of applications in nanomedicine, including drug delivery, controlled release, as well as disease diagnosis and treatment. Labeling AuNCs with radionuclides not only offers additional therapeutic capabilities but also makes it easy to analyze their biodistribution, monitor their uptake by the tissue or organ of interest, and optimize their performance in both diagnosis and treatment. Here, an introduction to the chemical synthesis and optical properties of AuNCs is provided in the beginning. The methods developed for their radiolabeling are then showcased, followed by the use of radiolabeled AuNCs in tracking and quantifying their pharmacokinetics, including biodistribution, tumor uptake, and intratumoral distribution. Finally, their potential applications in targeted imaging and image-guided therapy are discussed.
KW - cerenkov luminescence
KW - gold nanocages
KW - image-guided therapy
KW - molecular imaging
KW - radiolabeling
UR - http://www.scopus.com/inward/record.url?scp=85100162905&partnerID=8YFLogxK
U2 - 10.1002/adhm.202002031
DO - 10.1002/adhm.202002031
M3 - Review article
C2 - 33470560
AN - SCOPUS:85100162905
SN - 2192-2640
VL - 10
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 15
M1 - 2002031
ER -